NDC11 50881000603
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 50881-0006-03 | 50881-0006 |
| 50881-0006-3 | 50881-0006 |
| 50881-006-03 | 50881-006 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZYNYZ | RETIFANLIMAB-DLWR | Incyte Corporation | 109648d0-d30a-42fc-8273-39cb1540a751 | 2026-05-18 | Warnings, Adverse reactions | 50881-006-03 50881-006 50881000603 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.